Ticker Details
Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
IPO Date:	May 1, 2007
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$171.07M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 3.27%
Avg Daily Range (30 D):	$0.15 | 3.60%
Avg Daily Range (90 D):	$0.12 | 3.16%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	.29M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	162
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	83

Institutional Trades
Total Institutional Trades:	117
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$7.49M
Avg Institutional Trade (90 D):	$7.49M
Avg Institutional Trade Volume:	.21M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.68M
Avg Closing Trade (30 D):	$14.12M
Avg Closing Trade (90 D):	$14.12M
Avg Closing Volume:	372.95K

News

Jun 17, 2026 @ 12:55 PM Oramed Pharmaceuticals to Join Russell 2000® an... Source: Prnewswire

Mar 13, 2026 @ 12:00 PM Lifeward Receives Shareholder Approval to Close on... Source: Na

Jan 7, 2026 @ 1:55 PM Oramed Receives $18 Million Payment from Scilex Ho... Source: Prnewswire

Nov 17, 2025 @ 1:50 PM ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DIST... Source: Prnewswire

Feb 11, 2025 @ 2:15 PM Oramed Announces Transformative Joint Venture to A... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.53	$.23	$1.53
Diluted EPS	$1.5	$.24	$1.5
Revenue	$2M	$M	$2M
Gross Profit	$.01M	$M	$.01M
Net Income / Loss	$64.02M	$10.01M	$64.02M
Operating Income / Loss	$-15.09M	$-5.67M	$-15.09M
Cost of Revenue	$1.99M	$M	$1.99M
Net Cash Flow	$-8.47M	$-6.23M	$-8.47M
PE Ratio

Splits
Jan 23, 2013	1:12